Team

43 people, 25 full-time equivalents, across five research axes

L2IB brings together basic researchers, clinician-scientists and engineers from Inserm, CNRS, Université Claude Bernard Lyon 1, the ENS de Lyon and the Hospices Civils de Lyon. Women represent 63 % of the team and 43 % of its permanent staff.

Members are listed below under the axis they contribute to. Several people contribute to two axes and therefore appear twice; axis leads are marked.

À compléter — déposez les photos dans images/team/ (carré, ~400×400 px, .jpg), puis remplacez placeholder.svg par le nom du fichier. Grades et rattachements proviennent de l’organigramme HCERES arrêté au 31/12/2024.

Team leaders

Laurent Genestier Co-leader · DR2 Inserm

Emmanuel Bachy Co-leader · PU-PH


Axis 1 — Epigenetics and T-cell lymphoma

Laurent Genestier DR2 Inserm · Axis lead

Emmanuel Bachy PU-PH · Axis lead

David Armisen CR IRCCS

Alexandra Schrader Post-doc

Fabrice Chatonnet Post-doc

Edith Julia CCA

Amel Chebel IE UCBL

Emilie Bardel IE Inserm

Magali Perret IE, HCL

Sarah Sebai AI UCBL

Jonathan Lefebvre TR IRCCS

Marie Donzel PhD student

Leelou Picard M2 student

Axis 2 — Environment and genomic alterations in B-cell lymphoma

Pierre Sujobert PU-PH · Axis lead

Jean-Pierre Rouault CRHC CNRS · Axis lead

Alexandra Traverse-Glehen PU-PH

Sarah Huet MCU-PH

Evelyne Callet-Bauchu MCU-PH

Lucille Baseggio PH, HCL

Lionel Karlin PH, HCL

Sandrine Hayette CR, HCL

Aurélie Verney IE UCBL

Axel Conchon PhD student

Hedi Somai M2 student

Axis 3 — Metabolism and microenvironment in B-cell leukaemia

Carine Halfon-Domenech PU-PH · Axis lead

Melania Tesio CRCN Inserm · Axis lead

Ludovic Lhermitte MCU-PH

Thomas Schott Post-doc

Sarah Blanc TR, HCL

Erivan Demanou PhD student

Axis 4 — Inflammation in myeloid malignancies and VEXAS syndrome

Melania Tesio CRCN Inserm · Axis lead

Pierre Sujobert PU-PH · Axis lead

Maël Heiblig MCU-PH

Vincent Alcazer CCA

Laetitia Largeaud Post-doc

Marie Teixeira IR Inserm

Chrystelle Touller IE UCBL

Xinyue Fang PhD student

Mohamed Chour M2 student

Svetlana Le Ralle M2 student

Axis 5 — Immunotherapeutic intervention and CAR-T cells

Emmanuel Bachy PU-PH · Axis lead

Hervé Ghesquières PU-PH · Axis lead

Estelle Bourbon CCA

Nathalie Bissay AI IRCCS

Aurore Martin PhD student

Transversal axis — Omics, bioinformatics and AI

David Armisen CR IRCCS · Axis lead

Fabrice Chatonnet Post-doc

Vincent Alcazer CCA

Edith Julia CCA

Mohamed Chour M2 student

Svetlana Le Ralle M2 student

Hedi Somai M2 student

Administration

Stéphanie Ollier Administrative and financial management · AJT UCBL


Composition

43 people, 25 full-time equivalents.

Statutory position Count
DR2 Inserm · CRHC CNRS · CRCN Inserm 1 · 1 · 1
CR HCL · CR IRCCS 1 · 1
PU-PH / MCU-PH 9
PH 2
CCA 3
ITA / BIATSS (1 IR, 5 IE, 2 AI, 2 TR, 1 AJT) 11
Post-doctoral fellows 4
PhD students 5

Source: HCERES evaluation record, headcount as of 31 December 2024.

The official roster is also maintained on the CIRI website.